3.73
+0.05(+1.36%)
Currency In USD
| Previous Close | 3.68 |
| Open | 3.74 |
| Day High | 3.8 |
| Day Low | 3.69 |
| 52-Week High | 7.63 |
| 52-Week Low | 3.27 |
| Volume | 591,924 |
| Average Volume | 815,773 |
| Market Cap | 475.94M |
| PE | -74.6 |
| EPS | -0.05 |
| Moving Average 50 Days | 4.03 |
| Moving Average 200 Days | 5.35 |
| Change | 0.05 |
If you invested $1000 in Cytek Biosciences, Inc. (CTKB) since IPO date, it would be worth $198.83 as of May 07, 2025 at a share price of $3.73. Whereas If you bought $1000 worth of Cytek Biosciences, Inc. (CTKB) shares 3 years ago, it would be worth $476.98 as of May 07, 2025 at a share price of $3.73.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
GlobeNewswire Inc.
Apr 29, 2025 9:00 PM GMT
Company to Conduct Demonstrations, Educational Workshops and Tutorials at Key Industry EventsFREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) is showcas
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 8:05 PM GMT
FREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. Th
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
GlobeNewswire Inc.
Mar 18, 2025 9:00 PM GMT
Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® Muse® Micro is an affordable cell analyzer that simplifies flow cytometry while enhancing ease-of-use, precision and versatilit